A Mitochondria-Targeting Gold-Peptide Nanoassembly for Enhanced Cancer-Cell Killing
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Mitochondria-Targeting Gold-Peptide Nanoassembly for Enhanced Cancer-Cell Killing
Authors
Keywords
-
Journal
Advanced Healthcare Materials
Volume 2, Issue 12, Pages 1638-1643
Publisher
Wiley
Online
2013-05-08
DOI
10.1002/adhm.201300037
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Facile Preparation of Cationic Gold Nanoparticle-Bioconjugates for Cell Penetration and Nuclear Targeting
- (2012) Isaac Ojea-Jiménez et al. ACS Nano
- Design of Multifunctional Gold Nanoparticles for In Vitro and In Vivo Gene Silencing
- (2012) João Conde et al. ACS Nano
- Engineering Particles for Therapeutic Delivery: Prospects and Challenges
- (2012) Yan Yan et al. ACS Nano
- The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
- (2012) Alexandre Albanese et al. Annual Review of Biomedical Engineering
- Mitochondrial Control of Cellular Life, Stress, and Death
- (2012) Lorenzo Galluzzi et al. CIRCULATION RESEARCH
- Peptide-mediated cell penetration and targeted delivery of gold nanoparticles into lysosomes
- (2012) Chaitali D. Dekiwadia et al. JOURNAL OF PEPTIDE SCIENCE
- Negotiation of Intracellular Membrane Barriers by TAT-Modified Gold Nanoparticles
- (2011) Željka Krpetić et al. ACS Nano
- Strategy for Increasing Drug Solubility and Efficacy through Covalent Attachment to Polyvalent DNA–Nanoparticle Conjugates
- (2011) Xue-Qing Zhang et al. ACS Nano
- Cellular Uptake and Fate of PEGylated Gold Nanoparticles Is Dependent on Both Cell-Penetration Peptides and Particle Size
- (2011) Eunkeu Oh et al. ACS Nano
- Monolayer coated gold nanoparticles for delivery applications
- (2011) Subinoy Rana et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanoparticles in Biological Systems
- (2011) Wendelin J. Stark ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH
- (2011) Hyo Young Kim et al. BIOMATERIALS
- Multiple Triphenylphosphonium Cations as a Platform for the Delivery of a Pro-Apoptotic Peptide
- (2011) Netanel Kolevzon et al. PHARMACEUTICAL RESEARCH
- Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
- (2011) L. Agemy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gold Nanoparticles for Biology and Medicine
- (2010) David A. Giljohann et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeted delivery of a proapoptotic peptide to tumorsin vivo
- (2010) Sandrine Dufort et al. JOURNAL OF DRUG TARGETING
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Mechanisms of Endocytosis
- (2009) Gary J. Doherty et al. Annual Review of Biochemistry
- Cationic amphiphilic peptides with cancer-selective toxicity
- (2009) Frank Schweizer EUROPEAN JOURNAL OF PHARMACOLOGY
- Engineered Apoptosis-Inducing Peptides with Enhanced Mitochondrial Localization and Potency
- (2009) Kristin L. Horton et al. JOURNAL OF MEDICINAL CHEMISTRY
- Uptake and Intracellular Fate of Surface-Modified Gold Nanoparticles
- (2008) Paola Nativo et al. ACS Nano
- Binding to protein surfaces by supramolecular multivalent scaffolds
- (2008) Vera Martos et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Functional Gold Nanoparticle−Peptide Complexes as Cell-Targeting Agents
- (2008) Linlin Sun et al. LANGMUIR
- Mitochondrial Medicine: Pharmacological targeting of mitochondria in disease
- (2007) J S Armstrong BRITISH JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started